Phospho-Sin1 (Thr86) Antibody (Rabbit mAb) [L3G17]

Catalog No.: F7073

    Application: Reactivity:
    • Lane 1: Hela (serum-starved), Lane 2: Hela (serum-starved; hIGF-I, 100 ng/ml, 15 min), Lane 3: Hela (serum-starved; hIGF-I, 100 ng/ml, 15 min; λ phosphatase treated)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    59 kDa 78 kDa, 74 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール NIH/3T3 cells (Serum starved; insulin, 150 nM, 5 min); NIH/3T3 cells (Serum starved; hIGF-I, 100 ng/ml, 5 min)
    ネガティブコントロール NIH/3T3 cells (Serum starved)

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-Sin1 (Thr86) Antibody (Rabbit mAb) [L3G17] detects endogenous levels of total Sin1 protein only when it is phosphorylated at Thr86.
    タンパク質の局在
    細胞膜、細胞質、小胞体、エンドソーム、ゴルジ装置、リソソーム
    Uniprot ID
    Q9BPZ7
    Clone
    L3G17
    Synonym(s)
    JC310; MAPK associated protein 1; MAPKAP1; MEKK2-interacting protein 1; MGC2745; MIP1; SIN1; SIN1b; SIN1g; Target of rapamycin complex 2 subunit MAPKAP1; TORC2 subunit MAPKAP1
    Background
    Phosphorylation of Sin1 at threonine 86 (Thr86) represents a critical regulatory modification controlling the mechanistic target of rapamycin complex 2 (mTORC2), which comprises mTOR, rictor, Sin1, and mLST8 and functions as a key regulator of cell survival, growth, and cytoskeletal organization through phosphorylation of AGC kinase family members, including Akt at serine 473. Sin1 serves as an essential scaffolding component of mTORC2, and phosphorylation at Thr86 alongside Thr398 governs the integrity and catalytic activity of the entire mTORC2 complex through conformational changes that influence Sin1 association with other complex subunits. The functional consequences of Thr86 phosphorylation remain subject to cellular context, with two distinct regulatory paradigms emerging—Akt functions as the predominant kinase phosphorylating Sin1 at Thr86 across diverse cell lines and stimulation conditions, establishing a positive feedback loop wherein PDK1-mediated Akt phosphorylation at Thr308 generates partially active Akt that subsequently phosphorylates Sin1 at Thr86, enhancing mTORC2 kinase activity and enabling full Akt activation through mTORC2-mediated phosphorylation at Ser473. Conversely, phosphorylation of Sin1 at Thr86 and Thr398 by either S6K downstream of mTORC1 or by Akt itself triggers negative regulation by inducing Sin1 dissociation from the mTORC2 complex, thereby suppressing mTORC2 kinase activity and inhibiting Akt phosphorylation at Ser473 in response to insulin, IGF-1, PDGF, and EGF stimulation, establishing a feedback inhibition mechanism distinct from canonical IRS-1 and Grb10-mediated pathways. This dual regulatory capacity positions Thr86 phosphorylation as a molecular switch balancing mTORC2 activation and suppression depending on upstream signaling intensity, nutrient availability, and growth factor context. The phosphorylation state of Sin1 at Thr86 modulates mTORC2-dependent phosphorylation of additional substrates, including SGK1 at Ser422 and PKCα at Ser657, extending regulatory control beyond Akt to influence ion transport, cell migration, and membrane trafficking processes. Sin1 Thr86 phosphorylation integrates signals from both mTORC1 and growth factor receptor pathways, coordinating cellular responses to nutrient status and mitogenic stimulation through reciprocal crosstalk between mTORC1-S6K and mTORC2-Akt signaling axes. Cancer-associated mutations proximal to the Thr86 phosphorylation site, exemplified by the Sin1-R81T mutation identified from patient samples, impair phosphorylation-dependent negative regulation by preventing efficient phosphorylation, resulting in constitutive mTORC2 hyperactivation and sustained Akt signaling that drives oncogenic transformation, proliferation, and survival.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください